Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 3/2006

01-09-2006 | Article

Differential regulation of umbilical cord blood and leukemic B cells by interferon-alpha (IFN-α): Observations in cultured cells

Authors: István Szegedi, Csongor Kiss, Éva Karászi, György Vámosi, János Szöllösi, Péter Kovács, Ilona Benkő

Published in: Pathology & Oncology Research | Issue 3/2006

Login to get access
Metadata
Title
Differential regulation of umbilical cord blood and leukemic B cells by interferon-alpha (IFN-α): Observations in cultured cells
Authors
István Szegedi
Csongor Kiss
Éva Karászi
György Vámosi
János Szöllösi
Péter Kovács
Ilona Benkő
Publication date
01-09-2006
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2006
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/BF02893363

Other articles of this Issue 3/2006

Pathology & Oncology Research 3/2006 Go to the issue

Methods

A path or a new road in laboratory diagnostics? Biological mass spectrometry: Facts and perspectives

Article

Neuropathological spectrum of pilocytic astrocytoma-an Indian series of 120 cases

Case Report

Post-menopausal bleeding: a rare presentation of metastatic uveal melanoma

Article

Proteasome inhibitors sensitize colon carcinoma cells to TRAIL-induced apoptosis via enhanced release of smac/DIABLO from the mitochondria

Article

Immunohistochemical expression of p16 and p53 in vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva

Article

HER-2/neu genotype of breast cancer may change in bone metastasis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits